Literature DB >> 16901083

Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis.

Lauren M Pachman1, Adele L Boskey.   

Abstract

Pathologic deposition of mineral in the form of bone-like hydroxyapatite is a frequent occurrence in juvenile dermatomyositis (JDM) and other connective tissue diseases. Although the sizes of the mineral crystals in JDM are similar to those in bone, there is much more mineral in the deposits than there is in bone. Bone matrix proteins also accumulate associated with the deposits. The reasons for the formation of these deposits are not known. It is our hypothesis that persistent inflammation is a component of JDM and other hydroxyapatite deposition diseases. Other contributing factors are genetic, environmental, and physical chemical. This paper discusses the influence of inflammation on the deposition of hydroxyapatite, with emphasis on the clinical and environmental factors that may facilitate the formation of calcific deposits in JDM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16901083     DOI: 10.1007/s11926-996-0031-5

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  85 in total

1.  Degenerative mineralization in the fibrous capsule of silicone breast implants.

Authors:  André P Legrand; Georgi Marinov; Stoyan Pavlov; Marie-France Guidoin; Roger Famery; Bruno Bresson; Ze Zhang; Robert Guidoin
Journal:  J Mater Sci Mater Med       Date:  2005-05       Impact factor: 3.896

2.  Analysis of calcium deposits in calcific periarthritis.

Authors:  J Hamada; W Ono; K Tamai; K Saotome; T Hoshino
Journal:  J Rheumatol       Date:  2001-04       Impact factor: 4.666

3.  Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin.

Authors:  T Wada; M D McKee; S Steitz; C M Giachelli
Journal:  Circ Res       Date:  1999-02-05       Impact factor: 17.367

4.  Differential effects of aging on human chondrocyte responses to transforming growth factor beta: increased pyrophosphate production and decreased cell proliferation.

Authors:  F Rosen; G McCabe; J Quach; J Solan; R Terkeltaub; J E Seegmiller; M Lotz
Journal:  Arthritis Rheum       Date:  1997-07

5.  Treatment of dermatomyositis with intravenous gammaglobulin.

Authors:  B A Lang; R M Laxer; G Murphy; E D Silverman; C M Roifman
Journal:  Am J Med       Date:  1991-08       Impact factor: 4.965

6.  Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis.

Authors:  M B Oliveri; R Palermo; C Mautalen; O Hübscher
Journal:  J Rheumatol       Date:  1996-12       Impact factor: 4.666

7.  Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy.

Authors:  R M McDouall; M J Dunn; V Dubowitz
Journal:  J Neurol Sci       Date:  1990-11       Impact factor: 3.181

8.  MHC Class I overexpression on muscles in early juvenile dermatomyositis.

Authors:  Charles K C Li; Hemlata Varsani; Janice L Holton; Bin Gao; Patricia Woo; Lucy R Wedderburn
Journal:  J Rheumatol       Date:  2004-03       Impact factor: 4.666

9.  Light and electron microscopic observation on the process of tissue calcification in a case of parathyroid adenoma.

Authors:  N Monma; T Iwasaki; T Masuda; R Satodate
Journal:  Acta Pathol Jpn       Date:  1987-10

10.  Roles of alkaline phosphatase and labile internal mineral in matrix vesicle-mediated calcification. Effect of selective release of membrane-bound alkaline phosphatase and treatment with isosmotic pH 6 buffer.

Authors:  T C Register; F M McLean; M G Low; R E Wuthier
Journal:  J Biol Chem       Date:  1986-07-15       Impact factor: 5.157

View more
  8 in total

Review 1.  The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Authors:  Mark F Hoeltzel; Edward J Oberle; Angela Byun Robinson; Arunima Agarwal; Lisa G Rider
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

2.  Connective tissue mineralization in Abcc6-/- mice, a model for pseudoxanthoma elasticum.

Authors:  N Beril Kavukcuoglu; Qiaoli Li; Nancy Pleshko; Jouni Uitto
Journal:  Matrix Biol       Date:  2012-03-06       Impact factor: 11.583

3.  Calcium orthophosphates (CaPO4): occurrence and properties.

Authors:  Sergey V Dorozhkin
Journal:  Prog Biomater       Date:  2015-11-19

Review 4.  Calcium orthophosphates: occurrence, properties, biomineralization, pathological calcification and biomimetic applications.

Authors:  Sergey V Dorozhkin
Journal:  Biomatter       Date:  2011 Oct-Dec

5.  Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome.

Authors:  Isha Saini; Mani Kalaivani; Sushil Kumar Kabra
Journal:  Rheumatol Int       Date:  2016-03-23       Impact factor: 2.631

Review 6.  Calcinosis Biomarkers in Adult and Juvenile Dermatomyositis.

Authors:  Melody P Chung; Carrie Richardson; David Kirakossian; Amir B Orandi; Lesley A Saketkoo; Lisa G Rider; Adam Schiffenbauer; Carlos A von Mühlen; Lorinda Chung
Journal:  Autoimmun Rev       Date:  2020-03-28       Impact factor: 9.754

7.  Mitochondrial Calcification.

Authors:  Bhargavi Duvvuri; Christian Lood
Journal:  Immunometabolism       Date:  2021-01-29

8.  Microstructure and mineral composition of dystrophic calcification associated with the idiopathic inflammatory myopathies.

Authors:  Naomi Eidelman; Alan Boyde; Andrew J Bushby; Peter G T Howell; Jirun Sun; Dale E Newbury; Frederick W Miller; Pamela G Robey; Lisa G Rider
Journal:  Arthritis Res Ther       Date:  2009-10-26       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.